singl
import
respiratori
pathogen
infanc
earli
childhood
respiratori
syncyti
viru
rsv
approxim
primari
rsv
infect
children
result
lower
respiratori
tract
diseas
approxim
rsvqnfect
children
requir
hospit
especi
highrisk
children
primari
rsv
infect
result
signific
morbid
sometim
death
highrisk
group
includ
children
bronchopulmonari
dysplasia
children
congenit
heart
diseas
prematur
infant
less
month
age
children
immunodefici
diseas
estim
unit
state
infant
chronic
lung
diseas
infant
heart
diseas
identifi
month
age
children
hospit
annual
lower
respiratori
tract
diseas
caus
rsv
death
occur
report
institut
medicin
calcul
annual
hospit
cost
attribut
rsv
infect
million
data
collect
new
england
medic
center
show
averag
cost
hospit
child
rsv
day
difficulti
develop
safe
effect
rsv
vaccin
attent
focus
passiv
immun
use
rsv
immun
globulin
basi
recent
c
p
l
e
e
multiinstitut
trial
rsv
immun
globulin
appear
safe
costeffect
option
prevent
sever
rsv
diseas
highrisk
children
j
pediatr
virus
account
vast
major
upper
lower
respiratori
tract
infect
infant
children
includ
influenza
virus
parainfluenza
virus
adenovirus
coronavirus
rhinoviru
respiratori
syncyti
viru
rsv
singl
import
respiratori
pathogen
infanc
earli
childhood
asymptomat
carriag
rsv
appear
infrequ
occurr
approxim
primari
rsv
infect
confin
upper
airway
symptom
typic
common
cold
bronchopulmonari
dysplasia
defin
chronic
lung
diseas
preterm
ventilatorsupport
infant
character
persist
respiratori
distress
oxygen
requir
continu
beyond
first
month
life
radiograph
abnorm
recent
studi
nation
institut
child
health
human
develop
neonat
network
estim
bpd
develop
low
birth
weight
gm
ventilatorsupport
infant
born
unit
state
result
case
bpd
year
among
infant
born
year
unit
state
number
infant
birth
weight
gm
bpd
develop
may
increas
number
total
approxim
case
bpd
per
year
among
infant
children
bpd
viral
lrti
common
reason
rehospit
initi
hospit
discharg
prospect
studi
natur
histori
rsv
infect
children
bpd
groothui
et
al
found
infant
home
oxygen
program
acquir
rsv
infect
singl
respiratori
viru
season
hospit
requir
rsvinfect
infant
hospit
infant
hospit
day
admit
intens
care
unit
requir
mechan
ventil
recent
report
canada
review
experi
pediatr
tertiari
care
center
highrisk
infant
children
hospit
rsv
infect
pediatr
patient
hospit
chronic
lung
diseas
rsv
diseas
requir
supplement
oxygen
requir
intens
care
requir
mechan
ventil
seven
die
within
week
admiss
despit
ribavirin
therapi
studi
emphas
potenti
sever
lower
respiratori
tract
diseas
caus
rsv
infect
infant
young
children
preexist
lung
diseas
even
infant
children
older
year
age
chronic
lung
diseas
risk
rehospit
rsv
infect
children
categori
typic
recurr
recent
oxygen
requir
recent
studi
univers
colorado
found
pediatr
patient
hospit
rsv
diseas
older
month
age
infant
either
bpd
reactiv
airway
diseas
anoth
group
infant
children
chronic
lung
diseas
may
particularli
sever
rsv
diseas
cf
although
bacteri
infect
constitut
import
caus
acut
pulmonari
exacerb
popul
patient
cf
increas
risk
hospit
acut
respiratori
viru
infect
studi
abman
et
al
prospect
follow
infant
cf
diagnos
newborn
screen
program
infant
hospit
acut
respiratori
distress
reach
month
age
rsv
isol
hospit
infant
period
mean
durat
hospit
day
infant
requir
mechan
ventil
support
mean
followup
age
month
infant
cf
hospit
rsv
significantli
wors
chronic
respiratori
symptom
patient
cf
hospit
earli
life
rsv
infect
whether
sever
rsv
lrti
contribut
rapid
progress
chronic
chang
lung
patient
cf
whether
rsv
tend
sever
certain
patient
cf
extens
pulmonari
involv
known
either
explan
howev
recogn
rsv
infect
young
patient
cf
place
infant
increas
risk
infant
children
chd
constitut
second
group
patient
frequent
hospit
rsv
lrti
macdonald
et
al
evalu
effect
rsv
infect
infant
chd
prospect
studi
six
hundr
ninetynin
infant
follow
five
respiratori
viru
season
infant
chd
rsv
infect
rsvinfect
infant
chd
requir
day
intens
care
vs
like
requir
mechan
ventil
vs
control
group
infant
rsv
infect
chd
mortal
rate
rsvinfect
infant
chd
contrast
control
patient
overal
mortal
rate
infant
chd
without
rsv
infect
compar
mortal
rate
children
chd
rsv
infect
emphas
import
pathogen
caus
death
infant
chd
although
singl
anatom
lesion
predomin
infant
fatal
outcom
infant
heart
diseas
pulmonari
arteri
hypertens
greater
risk
fatal
outcom
previous
mention
canadian
report
review
experi
canadian
pediatr
tertiari
care
center
period
highrisk
infant
children
rsv
infect
chd
thirtythre
percent
hospit
rsvinfect
infant
chd
requir
intens
care
almost
requir
mechan
ventil
death
within
week
admiss
occur
cohort
chd
howev
among
infant
chd
pulmonari
arteri
hypertens
mortal
rate
twofold
higher
sever
possibl
explan
lower
mortal
rate
canadian
experi
studi
macdonald
et
al
advanc
cardiac
surgeri
intensivecar
manag
antivir
therapi
year
two
studi
like
improv
prognosi
despit
lower
mortal
rate
infect
rsv
continu
pose
signific
risk
infant
children
chd
incid
chd
unit
state
rang
per
live
birth
approxim
infant
per
risk
sever
lrti
caus
rsv
natur
cardiac
lesion
basi
birth
unit
state
estim
infant
chd
increas
risk
complic
hospit
caus
rsv
infect
infant
born
week
gestat
particularli
month
age
onset
rsv
infect
constitut
third
group
highrisk
infant
prospect
studi
univers
rochest
new
york
state
found
children
hospit
rsv
lrti
histori
prematur
even
absenc
lung
diseas
prematur
constitut
risk
factor
hospit
rsv
infect
demonstr
recent
report
cunningham
et
prospect
compar
cohort
survivor
born
week
gestat
match
control
group
term
infant
follow
year
assess
rate
rehospit
rsv
infect
thirtysix
percent
preterm
infant
without
bpd
rehospit
least
respiratori
ill
comparison
socioeconom
match
term
infant
twentyf
percent
preterm
infant
without
bpd
rehospit
compar
preterm
infant
histori
bpd
note
previous
term
infant
rehospit
thu
studi
preterm
infant
bpd
greatest
risk
rehospit
although
preterm
infant
histori
bpd
tenfold
increas
rehospit
rate
compar
control
infant
infant
discharg
septemb
decemb
approxim
three
time
like
rehospit
infant
discharg
may
august
reflect
import
respiratori
virus
precipit
readmiss
previous
describ
canadian
studi
hospit
highrisk
patient
prematur
risk
factor
among
prematur
pediatr
patient
chronic
lung
diseas
heart
diseas
immunodefici
proport
infant
admit
intens
care
unit
requir
mechan
ventil
similar
highrisk
group
thu
degre
prematur
histori
bpd
season
year
time
discharg
influenc
risk
rehospit
acut
respiratori
viru
ill
epidemiolog
studi
demonstr
term
neonat
tend
less
sever
rsv
diseas
first
week
life
matern
neutral
antibodi
titer
highest
sever
rsv
ill
tend
occur
passiv
acquir
matern
antibodi
level
fallen
low
level
term
infant
contrast
prematur
infant
like
high
incid
rsv
infect
sever
rsv
diseas
neonat
period
reflect
lower
titer
matern
neutral
antibodi
rsv
hospit
prematur
infant
repres
popul
greatest
risk
nosocomi
rsv
infect
comparison
symptom
older
infant
symptom
rsv
infect
neonat
often
nonspecif
without
symptom
lower
respiratori
tract
diseas
risk
nosocomi
rsv
diseas
function
length
hospit
group
prematur
infant
children
defici
immun
system
compos
fourth
group
high
risk
sever
rsv
infect
prospect
studi
hall
et
al
assess
relat
immun
statu
sever
rsv
infect
infant
children
year
age
hospit
respiratori
viru
season
rsv
infect
pediatr
patient
rsv
infect
immunocompromis
chemotherapi
steroid
therapi
primari
underli
immunodefici
children
immunocompromis
either
cancer
chemotherapi
primari
immunodefici
diseas
sever
rsv
diseas
children
normal
immun
statu
children
like
acquir
pneumonia
fatal
outcom
make
group
import
one
consider
rsv
prophylaxi
although
children
receiv
longterm
steroid
therapi
demonstr
significantli
greater
prolong
rsv
shed
appear
sever
diseas
children
normal
immun
statu
patient
immunosuppress
purpos
organ
transplant
repres
anoth
group
immunocompromis
patient
risk
sever
rsv
infect
bone
marrow
transplant
recipi
particular
increas
risk
infect
either
rsv
adenoviru
particularli
commun
epidem
rsv
infect
lower
respiratori
tract
rsv
may
associ
interstiti
pneumon
increas
mortal
rate
transplant
popul
report
univers
journal
pediatr
may
minnesota
describ
rsv
infect
bone
marrow
transplant
recipi
four
eight
patient
die
children
acquir
immunodefici
syndrom
constitut
anoth
categori
immunocompromis
patient
increas
risk
rsv
infect
hivinfect
patient
may
sever
ill
caus
rsv
measur
durat
ill
degre
hypoxia
temperatur
respiratori
rate
children
symptomat
hiv
infect
prolong
shed
rsv
comparison
normal
children
shed
rsv
averag
day
rang
day
viral
shed
month
document
hivinfect
infant
second
studi
found
increas
risk
pneumonia
mortal
rate
rsv
infect
hivinfect
children
interest
featur
rsv
infect
hivinfect
children
reduc
likelihood
wheez
cellmedi
immun
specif
lymphoprolif
respons
viral
antigen
believ
import
pathogenesi
bronchiol
wheez
dysfunct
aspect
immun
respons
postul
explan
absenc
wheez
addit
highrisk
group
includ
healthi
infant
week
age
becom
infect
rsv
studi
univers
pittsburgh
note
previous
well
infant
week
age
hospit
rsvinfect
significantli
like
requir
supplement
oxygen
spend
time
intens
care
unit
requir
longer
period
hospit
older
infant
studi
infant
week
age
hospit
mean
day
wherea
infant
week
age
hospit
day
infant
oxygen
satur
time
admiss
particular
risk
prolong
hospit
infant
month
age
experienc
mean
hospit
stay
day
typic
durat
older
nonhighrisk
infant
rsv
bronchiol
pneumonia
rsv
continu
caus
sever
diseas
sever
highrisk
group
highrisk
infant
children
increas
risk
prolong
hospit
respiratori
failur
compar
normal
children
rsv
infect
pediatr
popul
like
requir
supplement
oxygen
intens
care
tracheal
intub
mechan
ventil
report
stanford
medic
center
describ
random
doubleblind
placebocontrol
studi
ribavirin
therapi
infant
receiv
mechan
ventil
document
rsvinduc
respiratori
failur
mean
hospit
bill
infant
receiv
ribavirin
therapi
placebotr
patient
mean
hospit
bill
significantli
differ
studi
conduct
daili
cost
infant
hospit
new
england
medic
center
rsv
infect
report
institut
medicin
calcul
annual
hospit
cost
treatment
rsv
infect
million
figur
base
estim
hospit
treatment
rsv
infect
consider
total
econom
impact
rsv
note
mani
time
number
children
treat
outpati
recent
complet
multiinstitut
random
trial
demonstr
safeti
efficaci
hyperimmun
rsv
immun
globulin
highrisk
infant
children
cardiac
diseas
prematur
bpd
analysi
base
studi
show
rsvig
immunoprophylaxi
favor
costeffect
profil
hay
jw
ernst
rl
meissner
hc
unpublish
observ
although
rsvig
prophylaxi
may
save
medic
sector
resourc
averag
cost
per
year
life
save
figur
compar
favor
number
therapi
current
use
absenc
effect
rsv
vaccin
without
effect
antivir
agent
chemoprophylaxi
passiv
immunoprophylaxi
rsvig
hold
greatest
promis
reduc
morbid
mortal
rate
rsv
diseas
highrisk
patient
